AZD0530, AN INHIBITOR OF SRC KINASES, IN PLATINUM-PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A TRIAL OF THE PMH PHASE II CONSORTIUM

被引：0
|
作者：
Laurie, Scott A. [1 ]
Goss, Glenwood D. [1 ]
Shepherd, Frances A. [2 ]
Reaume, Neil [1 ]
Nicholas, Garth [1 ]
Philip, Lindsay [2 ]
Wang, Lisa [2 ]
Oza, Amit [2 ]
Hirsh, Vera [3 ]
Wright, James
Leighl, Natasha [2 ]
机构：
[1] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Mcgill Univ Hlth Ctr, Dept Oncol, Montreal, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
src kinase inhibitor; non-small cell; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1262 / S1262
页数：1
相关论文
共 50 条
  • [41] Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
    Sánchez, JM
    Balañá, C
    Font, A
    Sánchez, JJ
    Manzano, JL
    Guillot, M
    Margelí, M
    Richardet, M
    Rosell, R
    LUNG CANCER, 2002, 38 (03) : 309 - 315
  • [42] Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: A randomised phase II trial
    De Ruysscher, Dirk
    Bussink, Johan
    Rodrigus, Patrick
    Kessels, Alfons
    Dirx, Miranda
    Houben, Ruud
    Wanders, Rinus
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 (01) : 23 - 25
  • [43] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Xu, Ziyi
    Hao, Xuezhi
    Yang, Ke
    Wang, Qi
    Wang, Jing
    Lin, Lin
    Teng, Fei
    Li, Junling
    Xing, Puyuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3081 - 3089
  • [44] The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China
    Liu, You-ru
    Zhu, Wei
    Zhang, Jian-liang
    Huang, Jia-qi
    Zhao, Yi-zhuo
    Zhang, Wei
    Han, Bao-hui
    Yao, Yi-hong
    Jiang, Li-yan
    Li, Shan-qun
    CLINICAL RESPIRATORY JOURNAL, 2014, 8 (02) : 206 - 212
  • [45] Efficacy of tamoxifen in combination with docetaxel in patients with advanced non-small-cell lung cancer pretreated with platinum-based chemotherapy
    Wen, Shimin
    Fu, Xi
    Li, Guangming
    He, Lang
    Zhao, Caixia
    Hu, Xin
    Pan, Rongqiang
    Guo, Cuihua
    Zhang, Xinping
    Hu, Xingsheng
    ANTI-CANCER DRUGS, 2016, 27 (05) : 447 - 456
  • [46] Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer
    Furqan, Muhammad
    Abu-Hejleh, Taher
    Stephens, Laura M.
    Hartwig, Stacey M.
    Mott, Sarah L.
    Pulliam, Casey F.
    Petronek, Michael
    Henrich, John B.
    Fath, Melissa A.
    Houtman, Jon C.
    Varga, Steven M.
    Bodeker, Kellie L.
    Bossler, Aaron D.
    Bellizzi, Andrew M.
    Zhang, Jun
    Monga, Varun
    Mani, Hariharasudan
    Ivanovic, Marina
    Smith, Brian J.
    Byrne, Margaret M.
    Zeitler, William
    Wagner, Brett A.
    Buettner, Garry R.
    Cullen, Joseph J.
    Buatti, John M.
    Spitz, Douglas R.
    Allen, Bryan G.
    REDOX BIOLOGY, 2022, 53
  • [47] A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer
    Pallis, AG
    Agelidou, A
    Papakotoulas, P
    Tsaroucha, A
    Agelidou, M
    Agelaki, S
    Androulakis, N
    Vamvakas, L
    Gerogianni, A
    Kotsakis, A
    Kentepozidis, N
    Georgoulias, V
    LUNG CANCER, 2006, 52 (02) : 165 - 171
  • [48] Weekly paclitaxel combined with monthly carboplatin in elderly patients with advanced non-small cell lung cancer: A multicenter phase II study
    Pujol, Jean-Louis
    Milleron, Bernard
    Molinier, Olivier
    Quoix, Elisabeth
    Depierre, Alain
    Breton, Jean-Luc
    Gervais, Radj
    Debieuvre, Dither
    Hominal, Stephane
    Namouni, Fouad
    Tonelli, Dominique
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (04) : 328 - 334
  • [49] A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer
    Giannakakis, T
    Kakolyris, S
    Theodoropoulos, E
    Kouroussis, C
    Michailakis, E
    Papadouris, S
    Tsitoura, M
    Kalbakis, K
    Souglakos, J
    Agelaki, S
    Vardakis, N
    Georgoulias, V
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3743 - 3748
  • [50] A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer
    Clement-Duchene, Christelle
    Krupitskaya, Yelena
    Ganjoo, Kristen
    Lavori, Philip
    McMillan, Alex
    Kumar, Atul
    Zhao, Gary
    Padda, Sukhmani
    Zhou, Lisa
    San Pedro-Salcedo, Melanie
    Colevas, A. Dimitrios
    Wakelee, Heather A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (11) : 1821 - 1825
12345